
Episode 33: Pappas Capital's Art Pappas
BioVenture VoiCes with Chris Garabedian
00:00
Notable Exits and Approved Products
Art highlights successes including PARP inhibitors, migraine therapy development, and rare disease deals.
Play episode from 46:10
Transcript


